Johnson & Johnson's Revenue by Segment
In fiscal year 2024, Johnson & Johnson's revenue by segment (products & services) are as follows:
- Innovative Medicine: $56.96 B
- MedTech: $31.86 B
Learn more about Johnson & Johnson’s Revenue by Geography
Check out competitors to Johnson & Johnson in a side-by-side comparison.
Explore additional financial metrics for Johnson & Johnson.
Johnson & Johnson's Revenue Share by Segment
| Consumer | 14953000000 |
|---|---|
| Innovative Medicine | 52563000000 |
| MedTech | 27427000000 |
| Innovative Medicine | 54759000000 |
|---|---|
| MedTech | 30400000000 |
| Innovative Medicine | 56964000000 |
|---|---|
| MedTech | 31857000000 |
The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).
In fiscal year 2022, Johnson & Johnson's revenue by segment is as follows:
- Consumer generated $14.95 B in revenue, representing 15.75% of its total revenue.
- Innovative Medicine generated $52.56 B in revenue, representing 55.36% of its total revenue.
- MedTech generated $27.43 B in revenue, representing 28.89% of its total revenue.
The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 55.36% of its total revenue.
The smallest segment for Johnson & Johnson is the Consumer, which represents 15.75% of its total revenue.
The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).
In fiscal year 2023, Johnson & Johnson's revenue by segment is as follows:
- Innovative Medicine generated $54.76 B in revenue, representing 64.3% of its total revenue.
- MedTech generated $30.40 B in revenue, representing 35.7% of its total revenue.
The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.3% of its total revenue.
The smallest segment for Johnson & Johnson is the MedTech, which represents 35.7% of its total revenue.
The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).
In fiscal year 2024, Johnson & Johnson's revenue by segment is as follows:
- Innovative Medicine generated $56.96 B in revenue, representing 64.13% of its total revenue.
- MedTech generated $31.86 B in revenue, representing 35.87% of its total revenue.
The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.13% of its total revenue.
The smallest segment for Johnson & Johnson is the MedTech, which represents 35.87% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| Innovative Medicine | 55.36% | 64.3% | 64.13% |
| MedTech | 28.89% | 35.7% | 35.87% |
| Consumer | 15.75% | - | - |
| Total Revenue | 100% | 100% | 100% |
Johnson & Johnson's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Johnson & Johnson.
In fiscal year 2024, the Innovative Medicine generated the most revenue ($56.96 B), and the MedTech generated the least revenue ($31.86 B).
Johnson & Johnson's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
-
Pfizer Revenue by Segment
